Skip to content

Apimeds Pharmaceuticals US, Inc.

APUS· NYSECore metricsCIK 1894525

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -1.32%
Market cap
$4.16M
1.85M shares
Filings
131
$2.90M
Q3 2026
—
$33.65M
Q3 2026N/M FY25 yoy
$2.03M
Q3 2026N/M FY25 yoy
-$7.96M
Q3 2026derived
—
$7.68
Q3 2026N/M FY25 yoy
$17.91K
Q3 2026+4,085.3% FY25 yoy
$4.16M
—
—
0.0×
-216.09%
—

FY2025 figures · derived

Price

$2.2516.36%$0.44past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$2.90MQ3 2026
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Pharmaceutical preparations

Apimeds Pharmaceuticals US, Inc. is the 459th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Apimeds Pharmaceuticals US, Inc. · CIK 1894525 · Engraved from SEC EDGAR